SAN RAFAEL, Calif., Feb. 8, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the Leerink Partners 6(th) Annual Global Healthcare Conference on February 16, 2017 at 1:00pm ET, in New York City. Management will also participate in the Cowen and Company 37(th) Annual Health Care Conference on March 7, 2017 at 11:20am ET in Boston and the Barclays Global Healthcare Conference on March 15, 2017 at 8:00am ET, in Miami. To access the live webcasts, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of five commercialized products and multiple clinical and pre-clinical product candidates.

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.



    Contacts:

    Investors                                  Media

    Traci McCarty                              Debra Charlesworth

    BioMarin Pharmaceutical Inc.               BioMarin Pharmaceutical Inc.

    (415) 455-7558                             (415) 455-7451

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biomarin-to-attend-three-investor-conferences-in-1q17-300402955.html

SOURCE BioMarin Pharmaceutical Inc.